In neurodegenerative diseases such as ALS and FTD, cytoplasmic aggregates of TDP-43 are highly acetylated in patient tissue, and in experimental models, acetylated TDP-43 is more aggregation-prone [120]. Here, TARDBP is linked to neurodegenerative disease.